Advertisement

Topics

Companies Related to "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" [Most Relevant Company Matches] - Page: 2 RSS

14:18 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" found in our extensive corporate database of over 50,000 company records.

Showing "Study BuEAM Conditioning Autologous Stem Cell Transplantation ASCT" Companies 26–50 of 2,100+

Relevant

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem cell Research Institute in Korea. R-Japan’s proprietary technology is to isolate, multiply, and store adult mesenchymal stem cells with ensuring genetic integrity. R-Japan currently ...


Shenzhen Beike Biotechnology Company, Ltd.

Shenzhen Beike Biotechnology Co., Ltd. is China's leading biotechnology company focusing on the production of adult stem cells for use in medical therapies. Headquartered in Shenzhen (near Hong Kong) with a flagship regenerative medicine facility at the China Medical City in Jiangsu province, Beike produces a full line of stem cell products derived from umbilical cord, cord blood and autologou...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell th...


Gamida Cell

Gamida Cell is a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company’s pipeline of stem cell therapy products are in development to treat a wide range of conditions including blood cancers such as leukemia and lymphoma, solid tumors, autoimmune diseases, ...

Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. Vet-Stem hol...

Fate Therapeutics Inc.

Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation’s research hotbeds (Boston, San Francisco, San Diego and Seattle) who have demonstrated the potential to create and modulate st...

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias is focused on developing therapies to treat conditions in several medical areas where ther...

AuxoCell Laboratories, Inc.

AuxoCell Laboratories, Inc. (AuxoCell) is a leading stem cell therapeutic and regenerative medicine company located in Massachusetts. AuxoCell's primary research focus is to develop the enormous therapeutic potential of the primitive stem cells found in the Wharton's Jelly of the human umbilical cord. With exclusive patent rights and proprietary processing...

Genetics Policy Institute

GPI is a 501c3 nonprofit foundation with the mission to promote and defend stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders. GPI pursues this mission through production of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, ...

Nature Cell

Nature Cell (KOSDAQ: 007390) is a high-tech bio enterprise that runs Stem Cells business. The company has exclusive rights for business of products developed by Biostar Stem Cell Research Institute. More information about Nature Cell can be found at www.naturecell.co.kr.

Cellerant Therapeutics Inc.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in pa...

U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

Orthocell Limited

Orthocell is a commercial-stage, regenerative medicine company focused on regenerating mobility for patients and our ageing population by developing products for a variety of tendon, cartilage and soft tissue injuries. Orthocell’s portfolio of products include TGA-approved stem cell therapies Autologous Tenocyte Implantation (Ortho-ATI™) and Auto...

Stem Cell Therapeutics Corp.

Stem Cell Therapeutics is a publicly listed Canadian biotechnology company headquartered in Calgary, Alberta. The company is focused on the development and commercialization of Therapeutics that control adult stem cells in the body. We leverage the experience and expertise of our efficient team with numerous contract relationships.

Eligix Incorporated

BioTransplant Incorporated, based in Charlestown, Massachusetts, is developing therapeutics and systems around its unique and proprietary technology to re-educate the body's immune system to accept transplanted cells, tissues and organs by recognizing them as “self”. This technology is designed to overcome the serious side effects associated with organ transplantation or stem cell transplantat...

Gilbert, Arizona Economic Development Division

Gilbert, Arizona announces new cancer research and treatment center and stem cell research and treatment center. Banner Health has joined with MD Anderson to deliver unprecedented levels of cancer care at the new Banner MD Anderson Cancer Center in Gilbert, Arizona. This unique collaboration represents the broadest extension of MD Anderson’s cancer ca...

STEMTech HealthSciences Inc.

Founded in 2005 and headquartered in San Clemente, California, STEMTech HealthSciences Inc. is a pioneer in stem cell nutrition. Its patented flagship product, StemEnhance(R), co-invented by neurophysiologist Christian Drapeau and immunologist Dr. Gitte Jensen, was shown in a recent scientific study to promote an average 25% increase in the number of circulating adult stem cells. Recent scientific...

BioTransplant Incorporated

BioTransplant Incorporated, based in Charlestown, Massachusetts, is developing therapeutics and systems around its unique and proprietary technology to re-educate the body's immune system to accept transplanted cells, tissues and organs by recognizing them as “self”. This technology is designed to overcome the serious side effects associated with organ transplantation or stem cell transplantat...

BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is an emerging company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The patent pending technology is based on discoveries made by the scientific team led by Professor Eldad Melamed, former Head of Neurology at Rabin Medic...

CRYO-CELL

CRYO-CELL International, Inc. is the world's oldest & largest family cord blood stem cell bank. Since 1992 we've provided a high quality, superior value service to expectant parents for the private collection, processing & cryopreservation of their newborn's non-controversial U-Cord® stem cells.

Cellular Dynamics International (CDI)

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPS technology, the production of pluripotent stem ...

Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer and marketer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPSC technology, the production of plu...

Shenzhen Beike Biotechnology Co., Ltd.

Shenzhen Beike Biotechnology Co., Ltd. ("Beike") is China's leading biotechnology company whose scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of adult stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's stem cell therapies are administered by physician...

Vitro Diagnostics, Inc.

Vitro Diagnostics, Inc., dba Vitro Biopharma (OTCBB: VODG) (http://www.vitrobiopharma.com), owns U.S. patents for production of a fertility drug, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes. Vitro’s mission is “Harnessing the Power of Cells™” for the advancement of regenerative...

TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc. is a clinical-stage biotechnology company developing a novel therapeutic approach to restoring immune balance in transplantation and autoimmune disease. It’s proprietary platform technology, using autologous, polyclonally expanded T-regulatory cells was developed at Northwestern University by pioneer, Joseph R Leventhal, MD, P...


More From BioPortfolio on "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks